brd4 (Proteintech)
Structured Review
Brd4, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1296 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+brd4/c-Myc+Antibody/pm41874277-266-32-34
Average 96 stars, based on 1296 article reviews
Images
Related Articles
other:Article Title: BRD4-mediated transcriptional activation of PDLIM4 enhances p21 stability and chemosensitivity in lung adenocarcinoma independent of p53 Article Snippet: Primary antibodies which included anti-GAPDH (Cat. No. 60004–1-1 g), anti-BRD2 (Cat. No. 22236–1-AP), anti-BRD3 (Cat. No. 11859–1-AP), anti-BRD4 (Cat. No. 67374–2-1 g), anti-TUBULIN (Cat. No. 10094–1-AP), anti-FLAG (Cat. No. 66008–4-Ig), anti-HA (Cat. No. 51064–2-AP), anti-GFP (Cat. No. 50430–2-AP), and Article Title: The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC Article Snippet: The following antibodies were used: Anti-SPHK1( Chromatin Immunoprecipitation:Article Title: Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation. Article Snippet: Proteolysis targeting chimeras (PROTACs) hijack E3 ligases and the ubiquitin–proteasome system to achieve selective degradation of neo-substrates.. Their ability to target otherwise intractable substrates has rendered them a valuable modality in drug discovery.. However, only a handful of over 600 human E3 ligases have been functionalized for PROTAC applications. Flow Cytometry:Article Title: Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation. Article Snippet: Proteolysis targeting chimeras (PROTACs) hijack E3 ligases and the ubiquitin–proteasome system to achieve selective degradation of neo-substrates.. Their ability to target otherwise intractable substrates has rendered them a valuable modality in drug discovery.. However, only a handful of over 600 human E3 ligases have been functionalized for PROTAC applications. Magnetic Resonance Imaging:Article Title: Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation. Article Snippet: Proteolysis targeting chimeras (PROTACs) hijack E3 ligases and the ubiquitin–proteasome system to achieve selective degradation of neo-substrates.. Their ability to target otherwise intractable substrates has rendered them a valuable modality in drug discovery.. However, only a handful of over 600 human E3 ligases have been functionalized for PROTAC applications. Blocking Assay:Article Title: Inhibition of BRD4 Alleviates Pyroptosis Induced by Testicular Ischemia/Reperfusion Injury through the NLRP3 Pathway Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Incubation:Article Title: Inhibition of BRD4 Alleviates Pyroptosis Induced by Testicular Ischemia/Reperfusion Injury through the NLRP3 Pathway Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: USP22/BRD4 mediated hedgehog pathway activation contributes to airway remodeling in asthma. Article Snippet: .. Proteins were incubated with anti-USP22 (Abcam, ab195289, 1:40), |

